---
title: "Achieve生命科学 (ACHV.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ACHV.US/norm.md"
symbol: "ACHV.US"
name: "Achieve生命科学"
parent: "https://longbridge.com/zh-CN/quote/ACHV.US.md"
datetime: "2026-05-20T03:42:26.623Z"
locales:
  - [en](https://longbridge.com/en/quote/ACHV.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACHV.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACHV.US/norm.md)
---

# Achieve生命科学 (ACHV.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1905 | -0.2752 | -0.2831 | -0.3667 | -0.3698 |
| ROE | -252.65% | -212.75% | -153.46% | -195.86% | -329.13% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M |
| 营业利润 | -10.46M | -14.73M | -14.69M | -12.56M | -12.89M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 33.10M | 41.79M | 52.04M | 58.94M | 27.36M |
| 权益乘数 | 3.10 | 1.94 | 1.55 | 1.41 | 2.66 |
| 每股净资产 | 0.2006 | 0.4042 | 0.6365 | 0.8386 | 0.2964 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 29.27M | 36.40M | 48.11M | 55.40M | 23.25M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 49000.00 | 67000.00 | 79000.00 | 93000.00 | 106000.00 |
| 净债务 | -14.32M | -21.45M | -38.16M | -45.44M | -13.29M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -6.93M | -17.98M | -11.33M | -9.07M | -11.09M |
| 投资现金流 | 14.28M | 709000.00 | -12.65M | 6.70M | 11.35M |
| 融资现金流 | 21000.00 | 6.26M | 4.04M | 41.22M | - |
| 自由现金流 | -4.59M | -12.55M | -6.06M | -3.23M | -6.16M |
| 现金流充裕率 | - | -599233.33% | - | - | - |
| 举债与偿债 | - | 5.00M | - | - | - |
| 资本支出 | - | -3000.00 | - | - | - |